View in EDS

Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis.

Saved in:
Bibliographic Details
Title: Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis.
Authors: Poynton E; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Clinical Haematology, University College London Hospital, London, United Kingdom., Chernucha E; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Day J; Department of Clinical Haematology, University College London Hospital, London, United Kingdom., Prodger C; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Centre, Oxford, United Kingdom., Hopkins D; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Rakesh P; Centre for Clinical Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom., O'Neill T; Department of Haemato-Oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom., Thakrar N; Department of Clinical Haematology, University College London Hospital, London, United Kingdom., Akarca A; Department of Histopathology, University College London Hospital, London, United Kingdom., Jamal E; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Ali A; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom., Kirkwood AA; Cancer Research UK and UCL Cancer Trial Centre, UCL Cancer Institute, University College London, London, United Kingdom., Pomplun S; Department of Histopathology, University College London Hospital, London, United Kingdom., Marafioti T; Department of Histopathology, University College London Hospital, London, United Kingdom., Calaminici M; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom., Greaves P; Department of Haematology, Barking Havering and Redbridge University Hospital NHS Trust, Romford, United Kingdom., Chaganti S; Centre for Clinical Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom., McKay P; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom., Smith J; Clatterbridge Cancer Centre, Liverpool University Hospitals, Liverpool, United Kingdom., Eyre TA; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Centre, Oxford, United Kingdom., Martinez-Calle N; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom., Cwynarski K; Department of Clinical Haematology, University College London Hospital, London, United Kingdom., Fox CP; School of Medicine, University of Nottingham, Nottingham, United Kingdom., Okosun J; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
Source: Blood advances [Blood Adv] 2024 Apr 09; Vol. 8 (7), pp. 1772-1775.
Publication Type: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 38039509
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Poynton+E%22">Poynton E</searchLink>; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.; Department of Clinical Haematology, University College London Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Chernucha+E%22">Chernucha E</searchLink>; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Day+J%22">Day J</searchLink>; Department of Clinical Haematology, University College London Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Prodger+C%22">Prodger C</searchLink>; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Centre, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Hopkins+D%22">Hopkins D</searchLink>; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Rakesh+P%22">Rakesh P</searchLink>; Centre for Clinical Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22O'Neill+T%22">O'Neill T</searchLink>; Department of Haemato-Oncology, St. Bartholomew's Hospital, Barts Health NHS Trust, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Thakrar+N%22">Thakrar N</searchLink>; Department of Clinical Haematology, University College London Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Akarca+A%22">Akarca A</searchLink>; Department of Histopathology, University College London Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jamal+E%22">Jamal E</searchLink>; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Ali+A%22">Ali A</searchLink>; Cancer Research UK Clinical Trials Unit, University of Birmingham, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Kirkwood+AA%22">Kirkwood AA</searchLink>; Cancer Research UK and UCL Cancer Trial Centre, UCL Cancer Institute, University College London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Pomplun+S%22">Pomplun S</searchLink>; Department of Histopathology, University College London Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Marafioti+T%22">Marafioti T</searchLink>; Department of Histopathology, University College London Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Calaminici+M%22">Calaminici M</searchLink>; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Greaves+P%22">Greaves P</searchLink>; Department of Haematology, Barking Havering and Redbridge University Hospital NHS Trust, Romford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Chaganti+S%22">Chaganti S</searchLink>; Centre for Clinical Haematology, University Hospital Birmingham NHS Foundation Trust, Birmingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22McKay+P%22">McKay P</searchLink>; Beatson West of Scotland Cancer Centre, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Smith+J%22">Smith J</searchLink>; Clatterbridge Cancer Centre, Liverpool University Hospitals, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Eyre+TA%22">Eyre TA</searchLink>; Oxford University Hospitals NHS Foundation Trust, Churchill Cancer Centre, Oxford, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Martinez-Calle+N%22">Martinez-Calle N</searchLink>; Nottingham University Hospitals NHS Trust, Nottingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cwynarski+K%22">Cwynarski K</searchLink>; Department of Clinical Haematology, University College London Hospital, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Fox+CP%22">Fox CP</searchLink>; School of Medicine, University of Nottingham, Nottingham, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Okosun+J%22">Okosun J</searchLink>; Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2024 Apr 09; Vol. 8 (7), pp. 1772-1775.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Multicenter Study; Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38039509
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2023011426
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1772
    Titles:
      – TitleFull: Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Poynton E
      – PersonEntity:
          Name:
            NameFull: Chernucha E
      – PersonEntity:
          Name:
            NameFull: Day J
      – PersonEntity:
          Name:
            NameFull: Prodger C
      – PersonEntity:
          Name:
            NameFull: Hopkins D
      – PersonEntity:
          Name:
            NameFull: Rakesh P
      – PersonEntity:
          Name:
            NameFull: O'Neill T
      – PersonEntity:
          Name:
            NameFull: Thakrar N
      – PersonEntity:
          Name:
            NameFull: Akarca A
      – PersonEntity:
          Name:
            NameFull: Jamal E
      – PersonEntity:
          Name:
            NameFull: Ali A
      – PersonEntity:
          Name:
            NameFull: Kirkwood AA
      – PersonEntity:
          Name:
            NameFull: Pomplun S
      – PersonEntity:
          Name:
            NameFull: Marafioti T
      – PersonEntity:
          Name:
            NameFull: Calaminici M
      – PersonEntity:
          Name:
            NameFull: Greaves P
      – PersonEntity:
          Name:
            NameFull: Chaganti S
      – PersonEntity:
          Name:
            NameFull: McKay P
      – PersonEntity:
          Name:
            NameFull: Smith J
      – PersonEntity:
          Name:
            NameFull: Eyre TA
      – PersonEntity:
          Name:
            NameFull: Martinez-Calle N
      – PersonEntity:
          Name:
            NameFull: Cwynarski K
      – PersonEntity:
          Name:
            NameFull: Fox CP
      – PersonEntity:
          Name:
            NameFull: Okosun J
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 09
              M: 04
              Text: 2024 Apr 09
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1